v3.25.2
Segments (Tables)
6 Months Ended
Jun. 30, 2025
Segments [Abstract]  
Segment Data Segment data for the three months ending June 30, 2025 are as follows (in thousands):

Reportable

Chemed

VITAS

Roto-Rooter

Segments

Corporate

Consolidated

Service revenues and sales

$

396,201 

$

222,597 

$

618,798 

$

-

$

618,798 

Cost of services provided and goods sold

(excluding depreciation)

Wages

241,805 

75,704 

317,509 

-

317,509 

Patient care expense

41,008 

-

41,008 

-

41,008 

Other expenses

37,831 

37,757 

75,588 

-

75,588 

Total cost of services provided and goods sold

320,644 

113,461 

434,105 

-

434,105 

Selling, general and administrative expense

Wages

16,757 

21,018 

37,775 

2,748 

40,523 

Advertising

-

18,943 

18,943 

-

18,943 

Stock compensation

-

-

-

10,069 

10,069 

Other expenses

8,328 

20,575 

28,903 

1,885 

30,788 

Total selling, general and administrative expense

25,085 

60,536 

85,621 

14,702 

100,323 

Depreciation

5,314 

8,363 

13,677 

12 

13,689 

Amortization

26 

2,545 

2,571 

-

2,571 

Other operating expense/(income)

55 

(29)

26 

-

26 

Total costs and expenses

351,124 

184,876 

536,000 

14,714 

550,714 

Income/(loss) from operations

45,077 

37,721 

82,798 

(14,714)

68,084 

Interest expense

(47)

(129)

(176)

(267)

(443)

Intercompany interest income/(expense)

5,454 

3,970 

9,424 

(9,424)

-

Other income - net

61 

23 

84 

3,390 

3,474 

Income/(expense) before income taxes

50,545 

41,585 

92,130 

(21,015)

71,115 

Income taxes

(12,326)

(9,671)

(21,997)

3,375 

(18,622)

Net income/(loss)

$

38,219 

$

31,914 

$

70,133 

$

(17,640)

$

52,493 

Additions to long-lived assets

$

7,060 

$

8,745 

$

15,805 

$

5 

$

15,810 


Segment data for the three months ending June 30, 2024 are as follows (in thousands):

Reportable

Chemed

VITAS

Roto-Rooter

Segments

Corporate

Consolidated

Service revenues and sales

$

374,558 

$

221,322 

$

595,880 

$

-

$

595,880 

Cost of services provided and goods sold

(excluding depreciation)

Wages

212,811 

73,057 

285,868 

-

285,868 

Patient care expense

36,625 

-

36,625 

-

36,625 

Other expenses

36,081 

31,176 

67,257 

-

67,257 

Total cost of services provided and good sold

285,517 

104,233 

389,750 

-

389,750 

Selling, general and administrative expense

Wages

17,369 

20,002 

37,371 

4,367 

41,738 

Advertising

-

17,327 

17,327 

-

17,327 

Stock compensation

-

-

-

12,463 

12,463 

Other expenses

6,924 

20,022 

26,946 

3,781 

30,727 

Total selling, general and administrative expense

24,293 

57,351 

81,644 

20,611 

102,255 

Depreciation

5,058 

8,096 

13,154 

13 

13,167 

Amortization

26 

2,520 

2,546 

-

2,546 

Other operating expense/(income)

56 

(19)

37 

-

37 

Total costs and expenses

314,950 

172,181 

487,131 

20,624 

507,755 

Income/(loss) from operations

59,608 

49,141 

108,749 

(20,624)

88,125 

Interest expense

(46)

(118)

(164)

(265)

(429)

Intercompany interest income/(expense)

4,982 

3,540 

8,522 

(8,522)

-

Other income - net

46 

24 

70 

6,062 

6,132 

Income/(expense) before income taxes

64,590 

52,587 

117,177 

(23,349)

93,828 

Income taxes

(15,338)

(12,070)

(27,408)

4,467 

(22,941)

Net income/(loss)

$

49,252 

$

40,517 

$

89,769 

$

(18,882)

$

70,887 

Additions to long-lived assets

$

90,714 

$

5,552 

$

96,266 

$

164 

$

96,430 


Segment data for the first six months ending June 30, 2025 are as follows (in thousands):

Reportable

Chemed

VITAS

Roto-Rooter

Segments

Corporate

Consolidated

Service revenues and sales

$

803,600 

$

462,141 

$

1,265,741 

$

-

$

1,265,741 

Cost of services provided and goods sold

(excluding depreciation)

Wages

476,978 

153,176 

630,154 

-

630,154 

Patient care expense

81,387 

-

81,387 

-

81,387 

Other expenses

75,086 

78,008 

153,094 

-

153,094 

Total cost of services provided and goods sold

633,451 

231,184 

864,635 

-

864,635 

Selling, general and administrative expense

Wages

34,284 

42,204 

76,488 

7,479 

83,967 

Advertising

-

37,112 

37,112 

-

37,112 

Stock compensation

-

-

-

21,817 

21,817 

Other expenses

17,340 

43,868 

61,208 

1,806 

63,014 

Total selling, general and administrative expense

51,624 

123,184 

174,808 

31,102 

205,910 

Depreciation

10,509 

16,601 

27,110 

24 

27,134 

Amortization

52 

5,091 

5,143 

-

5,143 

Other operating expense/(income)

119 

(42)

77 

-

77 

Total costs and expenses

695,755 

376,018 

1,071,773 

31,126 

1,102,899 

Income/(loss) from operations

107,845 

86,123 

193,968 

(31,126)

162,842 

Interest expense

(95)

(261)

(356)

(416)

(772)

Intercompany interest income/(expense)

10,750 

7,900 

18,650 

(18,650)

-

Other income - net

110 

32 

142 

4,577 

4,719 

Income/(expense) before income taxes

118,610 

93,794 

212,404 

(45,615)

166,789 

Income taxes

(30,361)

(21,936)

(52,297)

9,758 

(42,539)

Net income/(loss)

$

88,249 

$

71,858 

$

160,107 

$

(35,857)

$

124,250 

Additions to long-lived assets

$

11,384 

$

18,186 

$

29,570 

$

5 

$

29,575 


Segment data for the first six months ending June 30, 2024 are as follows (in thousands):

Reportable

Chemed

VITAS

Roto-Rooter

Segments

Corporate

Consolidated

Service revenues and sales

$

728,564 

$

456,549 

$

1,185,113 

$

-

$

1,185,113 

Cost of services provided and goods sold

(excluding depreciation)

Wages

416,235 

151,591 

567,826 

-

567,826 

Patient care expense

71,699 

-

71,699 

-

71,699 

Other expenses

69,477 

65,875 

135,352 

-

135,352 

Total cost of services provided and goods sold

557,411 

217,466 

774,877 

-

774,877 

Selling, general and administrative expense

Wages

33,898 

41,077 

74,975 

8,307 

83,282 

Advertising

-

36,851 

36,851 

-

36,851 

Stock compensation

-

-

-

30,609 

30,609 

Other expenses

14,187 

40,683 

54,870 

12,516 

67,386 

Total selling, general and administrative expense

48,085 

118,611 

166,696 

51,432 

218,128 

Depreciation

10,225 

16,204 

26,429 

25 

26,454 

Amortization

52 

5,015 

5,067 

-

5,067 

Other operating expense

63 

66 

129 

-

129 

Total costs and expenses

615,836 

357,362 

973,198 

51,457 

1,024,655 

Income/(loss) from operations

112,728 

99,187 

211,915 

(51,457)

160,458 

Interest expense

(92)

(235)

(327)

(527)

(854)

Intercompany interest income/(expense)

10,176 

6,982 

17,158 

(17,158)

-

Other income - net

75 

47 

122 

18,587 

18,709 

Income/(expense) before income taxes

122,887 

105,981 

228,868 

(50,555)

178,313 

Income taxes

(29,666)

(24,610)

(54,276)

11,867 

(42,409)

Net income/(loss)

$

93,221 

$

81,371 

$

174,592 

$

(38,688)

$

135,904 

Additions to long-lived assets

$

96,569 

$

19,022 

$

115,591 

$

171 

$

115,762 

Identifiable Assets By Segment

June 30,

December 31,

2025

2024

VITAS

$

781,617 

$

839,568 

Roto-Rooter

543,950 

529,076 

Reportable segments

1,325,567 

1,368,644 

Corporate

392,280 

299,931 

Chemed consolidated

$

1,717,847 

$

1,668,575